STandard Versus No Opioid Prescription After Prolapse and Anti-INcontinence Surgery Trial

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

129 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-08-27

Study Completion Date

2022-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Overprescribing opioids is considered a major contributor to the opioid crisis. Hill et al. demonstrated that within a general surgery practice, over 70% of the prescribed opioid pills were never taken. Disturbingly, 45% of patients who did not take opioids at all on their day of discharge were discharged with an opioid prescription (Chen et al). Recent initiatives have attempted to utilize restrictive opioid prescribing protocols for postoperative pain management in which patients were prescribed a limited number of opioid tablets (Hallway et al) or prescribed opioids only if they were used as an inpatient (Mark et al). These well-conducted studies show that restrictive opioid prescribing policies achieve the goal of reducing excess opioid exposure without causing undue harm, inconvenience or dissatisfaction among patients.

The objective of this study is to determine if a restrictive opioid prescription protocol (in which patients are not prescribed postoperative opioids unless they request them) is acceptable to patients after ambulatory and major urogynecologic surgery, compared to standard opioid prescribing practices. The study investigators believe that physicians can capitalize on the new ability to electronically prescribe opioids for patients who require them, to prevent over-prescribing without impacting patient care. The study also intends to describe postoperative opioid use patterns in the urogynecologic population, including factors predictive of opioid use and non-use. The results of this research will have a significant and timely impact by helping to reduce opioid overprescribing and informing future prescribing guidelines in the field of urogynecology.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse Repair

NCT02502838

Overactive Bladder Pelvic Organ Prolapse

COMPLETED

Study of Overactive Bladder in Women With Prolapse

NCT01540214

Urinary Bladder, Overactive Pelvic Organ Prolapse

UNKNOWN

Does Spinal Anesthesia for Prolapse Surgery With Lead to Urinary Retention?

NCT02547155

Urinary Retention Uterine Prolapse

UNKNOWN NA

Is Preoperative Urodynamics Essential for Women With Pelvic Organ Prolapse

NCT04980196

Urogenital Prolapse

COMPLETED

Outcomes of Pelvic Surgery With and Without Anti-incontinence Procedure in Occult Stress Urinary Incontinence Patients

NCT02193607

Pelvic Organ Prolapse Stress Urinary Incontinence Other Specified Urinary Incontinence

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Specific Aims

Aim 1. To compare patient satisfaction and pain control using two different opioid prescribing protocols.

The study investigators hypothesize that postoperative pain control and satisfaction will be non-inferior between patients not routinely prescribed opioids after surgery and those prescribed a standard quantity. Participants will be asked to rate their pain control during the first 7 postoperative days with validated questionnaires. Participants' satisfaction with pain control will be evaluated at their postoperative visit.

Aim 2. To examine opioid use patterns after ambulatory and major urogynecologic surgery.

The study investigators hypothesize that most postoperative patients will use few or no opioids after urogynecologic surgery, regardless of prescribing protocol. All participants will receive thorough counseling with detailed instructions on non-opioid pain management, as well as multimodal analgesia via ERAS protocol during the perioperative period. Participants will be asked to log their opioid and non-opioid medication use in the first postoperative week. The investigators will also assess the number of requests for opioid prescription (in those randomized to the restrictive protocol) and opioid refills (from patients in the standard protocol).

Aim 3. To determine patient and perioperative factors associated with opioid use after urogynecologic surgery.

The study investigators plan to collect and analyze demographic, clinical and psychometric data on all participants with the goal of predicting analgesic needs and opioid use after urogynecologic surgery. Results from this study will guide surgeons on how to tailor opioid prescriptions to the needs of each patient, based off individual patient and perioperative characteristics.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Pain Opioid Use Prolapse; Female Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Opioid Protocol (Control)

Standard postoperative medications (opioids and non-opioids) are prescribed upon discharge after surgery

Group Type ACTIVE_COMPARATOR

Standard opioid prescribing

Intervention Type OTHER

Patients are routinely prescribed opioid medications in addition to non-opioids.

Restrictive Opioid Protocol (Intervention)

Only non-opioid analgesics (i.e. ibuprofen and acetaminophen) are prescribed upon discharge after surgery. Patients are allowed to request an opioid prescription if they so desire

Group Type EXPERIMENTAL

Restrictive opioid prescribing

Intervention Type OTHER

Patients are prescribed non-opioid pain medications, and will be prescribed opioids only if they request them.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard opioid prescribing

Patients are routinely prescribed opioid medications in addition to non-opioids.

Intervention Type OTHER

Restrictive opioid prescribing

Patients are prescribed non-opioid pain medications, and will be prescribed opioids only if they request them.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age greater than 18 years old
* Access to ancillary care, including phone advice, nurse and outpatient clinic numbers
* Transportation to outpatient clinic or ability to access Virtual Care Visits
* Able to speak and read English
* Has decision-making capacity and able to provide consent for research participation

Exclusion Criteria

* History of substance abuse disorder
* Chronic opioid use
* Score greater than or equal to 30 on Pain Catastrophizing Scale
* Allergy (not intolerance) to greater than or equal to 2 opioids
* Contraindications to both NSAIDs and acetaminophen
* Surgery scheduled on Friday or before major federal holiday
* Patients undergoing concomitant colorectal procedures
* Patients with perioperative complication (such as iatrogenic bowel and bladder injury, hemorrhage, unanticipated laparotomy or ICU admission)

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No